| dc.contributor |
AIDS Working Group, Médecins Sans Frontières, Paris, France. daniel.obrien@amsterdam.msf.org |
|
| dc.creator |
O'Brien, D P |
|
| dc.creator |
Sauvageot, D |
|
| dc.creator |
Olson, D |
|
| dc.creator |
Schaeffer, M |
|
| dc.creator |
Humblet, P |
|
| dc.creator |
Pudjades, M |
|
| dc.creator |
Ellman, T |
|
| dc.creator |
Zachariah, R |
|
| dc.creator |
Szumilin, E |
|
| dc.creator |
Arnould, L |
|
| dc.creator |
Reid, T |
|
| dc.date |
2007-05-01 |
|
| dc.date.accessioned |
2017-01-31T07:09:56Z |
|
| dc.date.available |
2017-01-31T07:09:56Z |
|
| dc.identifier |
Treatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings. 2007, 44 (9):1245-8 Clin. Infect. Dis. |
|
| dc.identifier |
1537-6591 |
|
| dc.identifier |
17407046 |
|
| dc.identifier |
10.1086/513433 |
|
| dc.identifier |
http://hdl.handle.net/10144/18270 |
|
| dc.identifier |
http://fieldresearch.msf.org/msf/handle/10144/18270 |
|
| dc.identifier |
Clinical Infectious Diseases |
|
| dc.identifier.uri |
http://dspace.mediu.edu.my:8181/xmlui/handle/10144/18270 |
|
| dc.description |
A study of 568 children aged <5 years who commenced nonnucleoside reverse-transcriptase inhibitor-based antiretroviral therapy in resource-limited settings revealed good early outcomes. After 12 months of antiretroviral therapy, survival probability was 0.89 (95% confidence interval, 0.86-0.92), with no significant difference among children stratified on the basis of baseline immunological levels; 62% attained a CD4 cell percentage >25%, and 7% continued to have a CD4 cell percentage <15%. |
|
| dc.language |
en |
|
| dc.publisher |
Published by: Infectious Diseases Society of America |
|
| dc.relation |
http://www.journals.uchicago.edu/page/cid/brief.html |
|
| dc.rights |
Archived on this site with permission and copyright by the Infectious Diseases Society of America |
|
| dc.title |
Treatment Outcomes Stratified by Baseline Immunological Status Among Young Children Receiving Nonnucleoside Reverse-Transcriptase Inhibitor-Based Antiretroviral Therapy in Resource-Limited Settings. |
|